<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>d532de78-53d7-4d1d-9c13-e155503e0172</id>
  <name>Cystic Fibrosis Respiratory Tract Agents Pediatric Order Group</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ï»© Technical Traceability</key>
        <value>{~AHSID~d532de78-53d7-4d1d-9c13-e155503e0172~NAME~Cystic Fibrosis Respiratory Tract Agents Pediatric Order Group}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;sodium chloride liquid inhalation 3%&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;4mL, inhalation, 2 times per day, Use nebulizer via oxygen&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Inhaled corticosteroids&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Combination inhalers&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Combination inhalers&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;fluticasone-vilanterol is restricted to:&lt;br&gt;1. Asthma uncontrolled on inhaled corticosteroid therapy OR&lt;br&gt;2. Maintenance treatment of moderate to severe (i.e. FEV1 less than 80% predicted) COPD&lt;br&gt;AND inadequate response to a long-acting bronchodilator OR&lt;br&gt;3. Maintenance treatment of severe (i.e. FEV1 less than 50% predicted) COPD&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Cystic Fibrosis Respiratory Tract Agents Pediatric">
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="034cf22a-244c-4426-ba87-2d75d1803327" concept_name="PHARM DORNASE ALFA 1 MG ML SOLUTION FOR INHALATION [12211] Order" max="1" path="/items" name="dornase alfa nebule 1 mg/mL; 2.5 mg inhalation daily, Administer via nebulizer with medical air 30 minutes before physio."/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="00ca502e-737c-4fe5-9109-4cf7eba0f738" concept_name="PHARM montelukast tablet chewable Compiled Order" max="1" path="/items" name="montelukast tablet chewable; 4 mg oral daily, at bedtime"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4448b55c-16c2-4fed-80cb-c5083623f5dd" concept_name="PHARM MONTELUKAST 10 MG TABLET [22509] Order" max="1" path="/items" name="montelukast tablet; 10 mg oral daily, at bedtime"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a1770ad9-2ff7-467b-a647-fd9aa7f9d922" concept_name="PHARM SODIUM CHLORIDE 7 Percent FOR NEBULIZATION [82134] Order" max="1" path="/items" name="sodium chloride liquid inhalation 7%; 4 mL inhalation every 4 hours, scheduled, Use nebulizer via oxygen"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c3f48a20-6f16-4097-aa4e-fdc6b452b93c" concept_name="PHARM SODIUM CHLORIDE 3 Percent FOR NEBULIZATION [7327] Order" max="1" path="/items" name="sodium chloride liquid inhalation 3%"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Inhaled corticosteroids">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1a3f4d60-374f-4c7c-9673-773890b259ee" concept_name="PHARM BECLOMETHASONE DIPROPIONATE 100 MCG ACTUATION AEROSOL INHALER [163282] Order" max="1" path="/items" name="beclomethasone inhaler 100 mcg; (QVAR); 1 puff inhalation 2 times per day, With spacer"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa80ca89-b938-4053-b4ab-6eaf57409b6f" concept_name="PLACEHOLDER Order Item" max="1" path="/items" name="PLACEHOLDER; budesonide (PULMICORT) 200 mcg/actuation inhaler; 1 puff inhalation 2 times per day"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a0658290-0341-4f98-b749-54b999b06de2" concept_name="PHARM CICLESONIDE HFA 100 MCG ACTUATION AEROSOL INHALER [92831] Order" max="1" path="/items" name="ciclesonide inhaler 100 mcg; (ALVESCO); 1 puff inhalation 2 times per day, With spacer"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4afce8da-a2a8-411c-89ae-f0868a875f9e" concept_name="PHARM CICLESONIDE HFA 200 MCG ACTUATION AEROSOL INHALER [92832] Order" max="1" path="/items" name="ciclesonide inhaler 200 mcg; (ALVESCO); 1 puff inhalation 2 times per day, With spacer"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c38d0a62-91f5-45a8-9c8b-a0ae54a2a997" concept_name="PHARM FLUTICASONE PROPIONATE 125 MCG ACTUATION HFA AEROSOL INHALER [166100] Order" max="1" path="/items" name="fluticasone propionate inhaler 125 mcg; (FLOVENT); 1 puff inhalation 2 times per day, With spacer"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f5104ebe-371c-4728-b6a8-13d34122e1b3" concept_name="PHARM FLUTICASONE PROPIONATE 250 MCG ACTUATION HFA AEROSOL INHALER [166101] Order" max="1" path="/items" name="fluticasone propionate inhaler 250 mcg; (FLOVENT); 1 puff inhalation 2 times per day, With spacer"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c76ae6d6-86d1-4f77-802b-eef0211f7137" concept_name="PHARM FLUTICASONE PROPIONATE 250 MCG ACTUATION BLISTER POWDER FOR INHALATION [28249] Order" max="1" path="/items" name="fluticasone propionate disk 250 mcg; (FLOVENT DISKUS); 1 puff inhalation 2 times per day"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Combination inhalers">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="177865c2-0c60-470e-a853-22dc478a7401" concept_name="PHARM FLUTICASONE PROPIONATE 125 MCG-SALMETEROL 25 MCG ACTUATION HFA INHALER [166068] Order" max="1" path="/items" name="fluticasone propionate-salmeterol inhaler 125 mcg-25 mcg; 1 puff inhalation 2 times per day, With spacer"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="695dca0f-4772-41bf-b6a8-9c5833f5735d" concept_name="PHARM FLUTICASONE PROPIONATE 250 MCG-SALMETEROL 25 MCG ACTUATION HFA INHALER [166067] Order" max="1" path="/items" name="fluticasone propionate-salmeterol inhaler 250 mcg-25 mcg; 1 puff inhalation 2 times per day, With spacer"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="52357da2-2a70-4287-b866-8c4853f3ee55" concept_name="PHARM FLUTICASONE 100 MCG-SALMETEROL 50 MCG DOSE BLISTR POWDR FOR INHALATION [104564] Order" max="1" path="/items" name="fluticasone propionate-salmeterol disk 100 mcg-50 mcg; 1 puff inhalation 2 times per day"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="16c5c507-466a-419c-a21b-c323ec06e299" concept_name="PHARM FLUTICASONE 250 MCG-SALMETEROL 50 MCG DOSE BLISTR POWDR FOR INHALATION [104565] Order" max="1" path="/items" name="fluticasone propionate-salmeterol disk 250 mcg-50 mcg; 1 puff inhalation 2 times per day"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="86102f5b-cd5a-4664-aeb1-b6f532ffc9fe" concept_name="PHARM FLUTICASONE 500 MCG-SALMETEROL 50 MCG DOSE BLISTR POWDR FOR INHALATION [104566] Order" max="1" path="/items" name="fluticasone propionate-salmeterol disk 500 mcg-50 mcg; 1 puff inhalation 2 times per day"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="6483e4ff-8631-45aa-83e6-04b1c2ac6662" concept_name="PHARM BUDESONIDE 100 MCG-FORMOTEROL 6 MCG BREATH ACTIVATED POWDER INHALER [166106] Order" max="1" path="/items" name="budesonide-formoterol inhaler 100 mcg-6 mcg; 1 puff inhalation 2 times per day"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="8d952840-1361-4072-ab99-181fd05a21a6" concept_name="PHARM BUDESONIDE 200 MCG-FORMOTEROL 6 MCG BREATH ACTIVATED POWDER INHALER [166107] Order" max="1" path="/items" name="budesonide-formoterol inhaler 200 mcg-6 mcg; 1 puff inhalation 2 times per day"/>
    </Item>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3da6e611-c8f1-449b-9dc4-e159d52b17a6" concept_name="PHARM SALBUTAMOL SULFATE HFA 100 MCG ACTUATION AEROSOL INHALER [165945] Order" max="1" path="/items" name="salbutamol inhaler 100 mcg/actuation; 2 puffs inhalation every 4 hours, Via MDI/spacer"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3da6e611-c8f1-449b-9dc4-e159d52b17a6" concept_name="PHARM SALBUTAMOL SULFATE HFA 100 MCG ACTUATION AEROSOL INHALER [165945] Order" max="1" path="/items" name="salbutamol inhaler 100 mcg/actuation; 2 puffs inhalation every 4 hours as needed for bronchospasm, Via MDI/spacer"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="26e9faa5-3e9a-42b2-924d-6b216c53a1fb" concept_name="PHARM TERBUTALINE 0.5 MG DOSE BREATH ACTIVATED POWDER INHALER [166627] Order" max="1" path="/items" name="terbutaline 0.5 mg/actuation inhaler; 1 puff inhaltion every 4 hours"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
</template>